Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis Subjects

NCT02378506 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

BIOLOGICAL: etanercept

Sponsor

Pfizer